Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • vandy
    Junior Member
    • Aug 2012
    • 5

    #1

    hybridization failure- Target exome sequencing Ion proton

    I am new to sequencing world. We are trying to perform library preparation for exome sequencing using Ion Proton. During the process there is three days hybridization step which got interrupted due to some power failure after 24hrs and samples were sitting at room temp for more than 16 hrs.

    We are in dilemma that should we continue with hybridization step or should we abort and start again with the new sample.

    Has anyone had this issue before?

    Can you suggest , whats the best possibility?

    Thanks in advance for all your suggestions.

    Regards

    vandy
  • JPC
    Senior Member
    • May 2008
    • 116

    #2
    Hi vandy, I assume you've moved on from this now, did you try and save the reaction? in my experience with Sureselect this step is extremely sensitive so we would have started again if this had happened to us

    JC

    Comment

    • vandy
      Junior Member
      • Aug 2012
      • 5

      #3
      Thanks JPC,
      We did go ahead for hybridisation and the sample qualified all most the QC steps

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
        by SEQadmin2




        NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
        Today, 06:46 AM
      • SEQadmin2
        Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
        by SEQadmin2



        Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

        Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
        ...
        10-14-2026, 09:55 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 10-28-2026, 09:57 AM
      0 responses
      24 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-28-2026, 09:51 AM
      0 responses
      15 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-22-2026, 11:13 AM
      0 responses
      68 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-22-2026, 10:48 AM
      0 responses
      48 views
      0 reactions
      Last Post SEQadmin2  
      Working...